Lorance L. Greenlee, J.D., Ph.D., has been in practice for 27 years and is the author of many pioneering biotechnology patents, including those for human and bovine growth hormone, recombinant hepatitis B virus, transgenic plants, and Bacillus thuringiensis expression in plants. Dr. Greenlee has significant corporate experience in patent strategy, licensing and technology transfer. Dr. Greenlee focuses his practice in medical science, molecular biology, genetics, immunology, plant sciences, chemistry and biochemistry. In addition to patent preparation and prosecution, Dr. Greenlee provides legal advice on patentability, patent strategy for pioneering fields of science, coordination of business and patent strategy, patent appeals, foreign patent practice, patent infringement and validity, freedom to operate, and licensing matters. Dr. Greenlee has an undergraduate degree in Chemistry from the University of Colorado, a doctorate in Biochemistry from Duke University, and was an associate professor of Biochemistry at the University of Utah prior to entering law school.